Whaley Glenn's Form 4 filing
Immunic, Inc. (IMUX) · filed Aug 11, 2021
- Accession no.
- 0001193805-21-001163
- Filed
- Aug 11, 2021
- Trade date
- Aug 10, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $14.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Whaley GlennCIK 0001724623 | Officer (PFO and PAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | PPurchaseAcquired | +1,500 | $9.85F1 | +$14,775 | 3,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of 1,500 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on August 10, 2021 at prices ranging from $9.65 to $9.95 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.